Name: SLE With High Disease Activity &amp; Potential Therapeutic Targets: Should LDA Be the Endpoint in Clinical Studies? Is Bimekizumab Safe and Effective in Ankylosing Spondylitis?
Uploaded: 2020-09-03T14:55:46.225953+00:00
Duration: 9 min 49 s
Description: SLE With High Disease Activity &amp; Potential Therapeutic Targets: Should LDA Be the Endpoint in Clinical Studies? Is Bimekizumab Safe and Effective in Ankylosing Spondylitis?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

Cleveland Clinic Medical Specialty Institute offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.